Needham analyst Kyle Peterson reiterated a Hold rating on Cardlytics (NASDAQ: CDLX).The analyst commented: 'CDLX's 4Q results beat expectations on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Cardlytics (CDLX) PT Lowered to $3 at Evercore ISIMarch 13, 2025 10:02 AM Cardlytics (CDLX) PT Lowered to $2.50 at BofA SecuritiesMarch 13, 2025 6:50 AM